Baculovirus capsid display potentiates OVA cytotoxic and innate immune responses

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Molinari, Paula ^a   Crespo, María I ^b   Gravisaco, María J ^a   Taboga, Oscar ^a   Morón, Gabriel ^b  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CAPSID PROTEIN; CYTOSINE; GUANOSINE; OVALBUMIN; THYMIDINE; VIRUS DNA; VIRUS VECTOR; IMMUNOLOGICAL ADJUVANT;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOGRAPHA CALIFORNICA; BACULOVIRUS; CD8+ T LYMPHOCYTE; CELL MATURATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATORY CELL; INNATE IMMUNITY; INSECT VIRUS; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYHEDROSIS VIRUS; T LYMPHOCYTE ACTIVATION; VIRUS CAPSID; VIRUS GENE; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; FLOW CYTOMETRY; GENETICS; IMMUNOELECTRON MICROSCOPY; IMMUNOLOGY; METABOLISM;

AUTOGRAPHA CALIFORNICA; DNA VIRUSES; HEXAPODA; MAMMALIA; MIRIDAE; MUS; NUCLEOPOLYHEDROVIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACULOVIRIDAE; CAPSID PROTEINS; CELL LINE; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 80052281901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024108     Document Type: Article

References (59)

1. Tjia ST, zu Altenschildesche GM, Doerfler W, (1983) Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 125: 107-117.
2. Volkman LE, Goldsmith PA, (1983) In vitro Survey of Autographa californica Nuclear Polyhedrosis Virus Interaction with Nontarget Vertebrate Host Cells. Appl Environ Microbiol 45: 1085-1093.
3. Abe T, Hemmi H, Miyamoto H, Moriishi K, Tamura S, et al. (2005) Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 79: 2847-2858.
4. Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, et al. (2003) Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 171: 1133-1139.
5. Hervas-Stubbs S, Rueda P, Lopez L, Leclerc C, (2007) Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 178: 2361-2369.
6. Kitajima M, Abe T, Miyano-Kurosaki N, Taniguchi M, Nakayama T, et al. (2008) Induction of Natural Killer Cell-dependent Antitumor Immunity by the Autographa californica Multiple Nuclear Polyhedrosis Virus. Mol Ther 16: 261-268.
7. Kitajima M, Takaku H, (2008) Induction of Antitumor Acquired Immunity by Baculovirus Autographa californica Multiple Nuclear Polyhedrosis Virus Infection in Mice. Clin Vaccine Immunol 15: 376-378.
8. Boublik Y, Di Bonito P, Jones IM, (1995) Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Biotechnology (N Y) 13: 1079-1084.
9. Tami C, Farber M, Palma EL, Taboga O, (2000) Presentation of antigenic sites from foot-and-mouth disease virus on the surface of baculovirus and in the membrane of infected cells. Arch Virol 145: 1815-1828.
10. Yoshida S, Kondoh D, Arai E, Matsuoka H, Seki C, et al. (2003) Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology 316: 161-170.
11. Mottershead D, van der Linden I, von Bonsdorff CH, Keinanen K, Oker-Blom C, (1997) Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem Biophys Res Commun 238: 717-722.
12. Peralta A, Molinari P, Conte-Grand D, Calamante G, Taboga O, (2007) A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties. Appl Microbiol Biotechnol 75: 407-414.
13. Blagborough AM, Yoshida S, Sattabongkot J, Tsuboi T, Sinden RE, (2010) Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission. Vaccine 28: 6014-6020.
14. Strauss R, Huser A, Ni S, Tuve S, Kiviat N, et al. (2007) Baculovirus-based Vaccination Vectors Allow for Efficient Induction of Immune Responses Against Plasmodium falciparum Circumsporozoite Protein. Mol Ther 15: 193-202.
15. Yoshida S, Kawasaki M, Hariguchi N, Hirota K, Matsumoto M, (2009) A baculovirus dual expression system-based malaria vaccine induces strong protection against Plasmodium berghei sporozoite challenge in mice. Infect Immun 77: 1782-1789.
16. Facciabene A, Aurisicchio L, La Monica N, (2004) Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 78: 8663-8672.
17. Kukkonen SP, Airenne KJ, Marjomaki V, Laitinen OH, Lehtolainen P, et al. (2003) Baculovirus capsid display: a novel tool for transduction imaging. Mol Ther 8: 853-862.
18. Federici BA, (1986) The Biology of Baculoviruses. Ultrastructure of baculovirus.; CRC Press B, Raton F, editors pp. 61-88.
19. O'Reilly DR, Miller LK, Luckow VA, (1994) Baculovirus expression vectors. A laboratory manual.
20. Schirmbeck R, Reimann J, Kochanek S, Kreppel F, (2008) The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens. Mol Ther 16: 1609-1616.
21. Abe T, Kaname Y, Wen X, Tani H, Moriishi K, et al. (2009) Baculovirus induces type I interferon production through toll-like receptor-dependent and-independent pathways in a cell-type-specific manner. J Virol 83: 7629-7640.
22. Grabherr R, Ernst W, Oker-Blom C, Jones I, (2001) Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins. Trends Biotechnol 19: 231-236.
23. Salminen M, Airenne KJ, Rinnankoski R, Reimari J, Valilehto O, et al. (2005) Improvement in nuclear entry and transgene expression of baculoviruses by disintegration of microtubules in human hepatocytes. J Virol 79: 2720-2728.
24. Wang P, Hammer DA, Granados RR, (1997) Binding and fusion of Autographa californica nucleopolyhedrovirus to cultured insect cells. J Gen Virol 78 (Pt 12): 3081-3089.
25. Whittaker GR, Helenius A, (1998) Nuclear import and export of viruses and virus genomes. Virology 246: 1-23.
26. Blissard GW, Wenz JR, (1992) Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion. J Virol 66: 6829-6835.
27. Kedl RM, Kappler JW, Marrack P, (2003) Epitope dominance, competition and T cell affinity maturation. Curr Opin Immunol 15: 120-127.
28. Rutigliano JA, Ruckwardt TJ, Martin JE, Graham BS, (2007) Relative dominance of epitope-specific CD8 T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. Virology 362: 314-319.
29. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, et al. (1994) The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153: 5586-5592.
30. Yewdell JW, Del Val M, (2004) Immunodominance in TCD8 responses to viruses: cell biology, cellular immunology, and mathematical models. Immunity 21: 149-153.
31. de Mare A, Lambeck AJ, Regts J, van Dam GM, Nijman HW, et al. (2008) Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition. Gene Ther 15: 393-403.
32. Naslund TI, Uyttenhove C, Nordstrom EK, Colau D, Warnier G, et al. (2007) Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor. J Immunol 178: 6761-6769.
33. Suzuki T, Chang MO, Kitajima M, Takaku H, (2010) Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses. Cell Immunol 262: 35-43.
34. Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, et al. (2010) Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 207: 1247-1260.
35. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, et al. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869.
36. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168: 4531-4537.
37. Wei J, Waithman J, Lata R, Mifsud NA, Cebon J, et al. (2010) Influenza A infection enhances cross-priming of CD8 T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion. J Immunol 185: 6013-6022.
38. Rajagopal D, Paturel C, Morel Y, Uematsu S, Akira S, et al. (2010) Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists. Blood 115: 1949-1957.
39. Kuwajima S, Sato T, Ishida K, Tada H, Tezuka H, et al. (2006) Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat Immunol 7: 740-746.
40. Di Pucchio T, Chatterjee B, Smed-Sorensen A, Clayton S, Palazzo A, et al. (2008) Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol 9: 551-557.
41. Hoeffel G, Ripoche AC, Matheoud D, Nascimbeni M, Escriou N, et al. (2007) Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27: 481-492.
42. Mouries J, Moron G, Schlecht G, Escriou N, Dadaglio G, et al. (2008) Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood 112: 3713-3722.
43. Reschner A, Hubert P, Delvenne P, Boniver J, Jacobs N, (2008) Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin Exp Immunol 152: 219-226.
44. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM, (2004) The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199: 1607-1618.
45. Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, et al. (2003) NKT cells enhance CD4 and CD8 T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171: 5140-5147.
46. Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, et al. (2004) Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 114: 1800-1811.
47. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H, (1996) Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 14: 207-232.
48. Russell JH, Ley TJ, (2002) Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20: 323-370.
49. Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR, (2009) Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control. Eur J Immunol 39: 2725-2736.
50. Andreasson K, Eriksson M, Tegerstedt K, Ramqvist T, Dalianis T, (2010) CD4 and CD8 T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particles. PLoS One 5: e11580.
51. Nowak AK, Lake RA, Robinson BW, (2006) Combined chemoimmunotherapy of solid tumours: improving vaccines? Adv Drug Deliv Rev 58: 975-990.
52. Goldberger O, Volovitz I, Machlenkin A, Vadai E, Tzehoval E, et al. (2008) Exuberated numbers of tumor-specific T cells result in tumor escape. Cancer Res 68: 3450-3457.
53. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
54. Karttunen J, Sanderson S, Shastri N, (1992) Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 89: 6020-6024.
55. Falo LD Jr, Kovacsovics-Bankowski M, Thompson K, Rock KL, (1995) Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med 1: 649-653.
56. Shen CF, Meghrous J, Kamen A, (2002) Quantitation of baculovirus particles by flow cytometry. J Virol Methods 105: 321-330.
57. Moron G, Rueda P, Casal I, Leclerc C, (2002) CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8 T cells and subsequently express CD8alpha and CD205 molecules. J Exp Med 195: 1233-1245.
58. Maletto BA, Ropolo AS, Liscovsky MV, Alignani DO, Glocker M, et al. (2005) CpG oligodeoxinucleotides functions as an effective adjuvant in aged BALB/c mice. Clin Immunol 117: 251-261.
59. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.